(Reuters) - Gene sequencing company Illumina Inc (O:ILMN) said http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u= on Thursday it plans to buy Pacific Biosciences of California Inc (O:PACB) in an all-cash deal valued at $1.2 billion.
Illumina's offer of $8 per Pacific share represents a premium of about 77 percent to Pacific's Thursday close.